Upexi, Inc. UPXI TECH
Company Overview
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.
Why Investors Should Care
Revenue has grown at a 16.4% CAGR over the past five years.
Trades at a P/E of 2.0, below the sector median of 17.0.
Carries low leverage with a debt-to-equity ratio of 0.31.
Recent Developments
- Jun 2025 Revenue of $15.81M (-39.2% YoY); net profit $-13.68M.
- Trailing 12 Months Year-on-year growth — revenue +44.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 16.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 16.36% |
| 1 Year: | 44.20% |
Stock Price Performance
| 1 Year: | -86.72% |
| 6 Months: | +7.22% |
| 3 Months: | +9.47% |
| 1 Month: | +22.21% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)55.58 · Neutral
P/E of 1.96 is below the sector median of 16.99 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 16.4% over 5 years.
CONS
- Trading 87.8% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Communication Services).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | UPXI Upexi, Inc. TECH | 1.04 | 1.96 | $85.39M | 0.00% | -14.11% | -15.19% | 16.36% | - |
| 2 | GOOGL Alphabet Inc. NDXSPXR3KAITECH | 338.36 | 16.97 | $1.99T | 0.25% | 26.20% | 48.68% | 17.96% | 21.53% |
| 3 | META Meta Platforms, Inc. NDXSPXR3KAITECH | 613.48 | 23.12 | $1.35T | 0.31% | 25.69% | 29.85% | 19.89% | 37.61% |
| 4 | NFLX Netflix, Inc. NDXSPXR3KAI | 76.77 | 24.14 | $319.67B | 0.00% | 29.87% | 49.54% | 22.30% | 32.79% |
| 5 | VZ Verizon Communications Inc. SPXR3K | 50.41 | 13.13 | $209.44B | 5.86% | 8.56% | 15.84% | 2.33% | 6.90% |
| 6 | TMUS T-Mobile US, Inc. NDXSPXR3K | 181.69 | 19.03 | $194.89B | 2.45% | 9.39% | 17.99% | 22.63% | 28.77% |
| 7 | DIS The Walt Disney Company SPXR3K | 105.06 | 21.66 | $181.41B | 1.43% | 10.74% | 8.01% | 6.96% | 4.12% |
| 8 | T AT&T Inc. SPXR3K | 25.60 | 8.45 | $175.42B | 4.37% | 6.59% | 18.34% | 0.31% | 3.44% |
| 9 | SPOT Spotify Technology S.A. R3KAITECH | 528.64 | 28.81 | $108.70B | 0.00% | 24.61% | 44.48% | 13.59% | - |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2020 | Dec 2020 | Mar 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.16M | 4.29M | 9.24M | 8.05M | 4.56M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.60M | 884.10K | 956.75K | 1.34M | 206.37K |
| Gross Profit | 1.32M | 1.93M | 3.40M | 2.60M | 4.27M | 3.33M | 5.82M | 10.09M | 7.58M | 5.43M | 4.57M | 1.27M | 2.93M | - | 1.56M | 3.40M | 8.28M | 6.71M | 4.35M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.41M | 10.02M | 17.12M | 15.82M | 10.17M |
| Operating Income | -760.09K | -243.29K | 1.02M | -879.13K | -2.54M | -1.54M | -2.38M | -1.70M | -2.13M | -1.46M | -2.60M | -5.04M | -1.34M | - | -3.85M | -6.61M | -8.84M | -9.11M | -5.82M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.63M | -6.57M | 69.60M | -8.95M | -5.71M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.70M | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.83M | -6.93M | 66.75M | -178.92M | -109.34M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Net Income | -809.07K | 102.52K | 966.76K | 511.71K | 64.83K | -52.67K | -2.75M | 2.58M | -1.77M | -1.36M | -2.44M | -4.12M | -1.63M | - | -3.83M | -6.93M | 66.75M | -178.92M | -109.34M |
| Diluted EPS | -0.08 | 0.01 | 0.07 | 0.03 | -0.32 | 0.00 | -0.16 | 0.14 | -0.11 | -1.34 | -2.00 | -4.03 | 1.55 | -1.24 | -2.87 | - | 0.76 | -2.94 | -1.67 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|
| Revenue | 7.41M | 24.10M | 23.07M | 36.44M | 26.00M | 15.81M |
| Cost of Revenue | - | - | 8.20M | 15.42M | 13.18M | 4.94M |
| Gross Profit | 2.57M | 11.90M | 14.87M | 21.02M | 12.82M | 10.87M |
| Operating Expenses | - | - | 21.36M | 29.55M | 26.22M | 23.74M |
| Operating Income | -4.84M | 1.43M | -6.49M | -8.53M | -13.40M | -12.88M |
| EBITDA | - | - | -3.76M | -5.05M | -9.72M | -12.12M |
| Interest Expense | - | - | - | - | - | - |
| Pretax Income | - | - | -6.39M | -16.96M | -25.60M | -13.68M |
| Tax Provision | - | - | -518.40K | -3.05M | -332.10K | 0 |
| Net Income | -5.38M | 2.98M | -2.10M | -16.93M | -23.66M | -13.68M |
| Diluted EPS | -0.53 | 0.21 | -8.60 | -18.94 | -23.03 | -1.73 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | 6.40M | 27.25M | 48.49M | 63.80M | 23.51M | 123.81M |
| Current Assets | - | - | - | 17.06M | 30.01M | 11.42M | 56.78M |
| Cash & Equivalents | 3.70M | 887.52K | 14.53M | 7.15M | 4.49M | 661.41K | 2.98M |
| Inventory | - | - | - | 4.73M | 4.80M | 1.43M | 1.15M |
| Receivables | - | - | - | 939.88K | 1.13M | 606.88K | 157.51K |
| Total Liabilities | - | - | - | 19.70M | 35.96M | 17.00M | 33.71M |
| Current Liabilities | - | 3.52M | 5.82M | 10.13M | 22.39M | 12.66M | 32.56M |
| Long Term Debt | - | - | - | 8.88M | 13.57M | 2.61M | - |
| Total Debt | - | - | - | 15.19M | 26.34M | 13.45M | 27.78M |
| Total Equity | 6.40M | 2.18M | 21.22M | 28.73M | 28.34M | 6.52M | 90.10M |
| Shares Outstanding | - | - | - | 835.67K | 1.01M | 1.05M | 38.27M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.16M | 2.94M | 715.15K | 202.68K | -101.38K | -8.42M |
| Investing Cash Flow | -1.46M | -1.28M | -10.90M | -2.57M | -3.38M | -99.29M |
| Financing Cash Flow | 2.82M | 11.99M | 3.70M | -285.33K | -353.79K | 110.03M |
| Capital Expenditure | -1.93M | -1.42M | -5.45M | -937.56K | -932.57K | -387.76K |
| Free Cash Flow | -6.09M | 1.52M | -4.74M | -734.89K | -1.03M | -8.81M |
| Net Change in Cash | - | - | -7.38M | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | 34.7% | 49.4% | 64.5% | 57.7% | 49.3% | 68.7% |
| Operating Margin % | -65.3% | 5.9% | -28.1% | -23.4% | -51.5% | -81.4% |
| Net Margin % | -72.6% | 12.4% | -9.1% | -46.5% | -91.0% | -86.5% |
| ROE % | -247.1% | 14.0% | -7.3% | -59.7% | -363.1% | -15.2% |
| ROCE % | -167.8% | 6.7% | -16.9% | -20.6% | -123.4% | -14.1% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Arrington Capital Management, LLC | 3.51% | 2.76M | $3.28M |
| 2 | Vanguard Capital Management LLC | 3.06% | 2.41M | $2.87M |
| 3 | MMCAP International, Inc. SPC | 2.96% | 2.33M | $2.77M |
| 4 | Blackrock Inc. | 1.13% | 888.91K | $1.06M |
| 5 | Osaic Holdings Inc. | 0.98% | 770.24K | $916.58K |
| 6 | Susquehanna International Group, LLP | 0.89% | 703.13K | $836.72K |
| 7 | Geode Capital Management, LLC | 0.74% | 582.89K | $693.64K |
| 8 | Vanguard Fiduciary Trust Co | 0.40% | 311.36K | $370.52K |
| 9 | Millennium Management Llc | 0.34% | 271.22K | $322.75K |
| 10 | UBS Group AG | 0.30% | 232.21K | $276.32K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for UPXI
More than 2 million Solana tokens are held by Upexi. Its strategy chief will meet investors Sept. 15. - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxOMDcwSEJiRWlIZzhMTnVxdV9iWUNTQmItMDNYUEdEODJTdTNCUnRZMjVHTjdmRktHcy02aFpIcFhLR0VzUFMtZy1kMlVlNy1uMjdtUFY4Zl9reU02QTFUT0JzTTJicGJUSmVXUUJ4QXc3SkVISGw4Y1lqOTNIbUhvYXotSEV4Z1J0TW40bH…
UPEXI ($UPXI) Releases Q3 2026 Earnings | UPXI Stock News - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxQRmYzSGIwd2xUclprM1pfVy1JX1QyR0pJaFB0b2FKd1FpSEE1aWd4MnY2dV9YRjNxcjV6a19sVzROOGxVd3ZiekJ1MGFvWFcwREtnaWZ3UkRUNy1zQzd2MkxDaXl1WXVBaFRtUVJ6ZWZleV91U2lVYlQtQVRYUTNrN2tQRlU?oc=5" targ…
Upexi to Participate in FT Partners FinTech Conference 2026 on September 15th - marketscreener.com
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxONjI5MklBS2JQQm5DWHlOSXNKdVR2NTB5V29vZnBlMzV1Ym90Y1Q5WXRVQXlXdGlRRkYtd0JjeFozd21adkxiYUxrMTM5RDBraUpxcXFiX2xjc2s4eUp5b21LeWJ3QU0wZUJHMFlWRjBpdE1uYjd5TGRoUl9hV2ptU2lOU2ZUUEx0Q05KNH…
UPXI - Finviz
<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTFBsVk1FOFFuS3dzMko5b2o0dDVBSk9fVFR1U3Z3aERhaUJSM2hKMlEwZDZSanFKaFlBV2FOWXdJYzRhVUFGX2c?oc=5" target="_blank">UPXI</a> <font color="#6f6f6f">Finviz</font>…
UPXI Forecast — Price Target — Prediction for 2027 - tradingview.com
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTFBFbXlqMXZvSlk4WERHZEI5X1o2SlF0NEtlNHE4V2wyUVYwUVRpcjduUUFUbkxHWTB3ZUVVbGg0eWdIYkpPdEVOUmFMYW9sajJzRnk5UzlXUkE0QkY2b2JPRnpBSFc2NlVTU2dzbEFneFhVT2Y0Q2xzTmVB?oc=5" target="_blank">UPX…
Upexi (UPXI) Expected to Release Earnings on Wednesday - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNbTM5V0RZRFpkRjF2VUNEeUpNQUFpX21lS1FiUVZGdUdCWkhmVmU5RkJndFBPNXlCTkQ4MzV4VW5RdVFXd3ZtazR2NUxVNFJBT2gtVF80MEZXUFFrcWhrNUF6TnVUbEY5ZnVMOUR3Xy1iNkhTenVXbTlsbG01OVZTZGp2QUxyTHFfbW9GSU…
UPXI — Frequently Asked Questions
What is the current share price of Upexi, Inc. (UPXI)?
As of 2026-09-19 21:16 PDT, Upexi, Inc. (UPXI) trades at $1.04 on NasdaqCM. Its 52-week range is $0.56 to $8.56.
What is the market capitalisation of UPXI?
Upexi, Inc. (UPXI) has a market capitalisation of $85.39M on NasdaqCM.
What is the P/E ratio of UPXI?
UPXI trades at a trailing price-to-earnings (P/E) ratio of 1.96. The industry average P/E is 16.99. Its price-to-book (P/B) ratio is -1.53.
What is the return on equity (ROE) of UPXI?
UPXI has a return on equity (ROE) of -15.19%. Its return on capital employed (ROCE) is -14.11%.
Is UPXI a good stock to buy?
This page provides a data-driven analysis of Upexi, Inc. (UPXI), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.